An overlooked micro-cap stainless-steel specialist is scaling modular biopharma manufacturing—turning a record backlog and a new facility into potential earnings re-rating power.
Overview
Paul Mueller Company (MUEL), founded in 1940 in Springfield, Missouri, has evolved into a specialized manufacturer of high-purity stainless-steel process equipment serving dairy, food & beverage, and increasingly pharmaceutical/biotech markets. Its value proposition centers on engineering and fabricating sanitary, regulated systems meeting stringent standards (e.g., ASME pressure vessels and USP-related pure water/steam requirements). Operations span four segments: Industrial Equipment (largest; custom tanks, pure water equipment, heat transfer products for pharma/biotech), Refrigeration & Heat Transfer (dairy cooling/storage and heat recovery), European Operations (Mueller B.V. serving EMEA/APAC), and Transportation (logistics support that reduces external supply-chain friction). Core offerings include PyroPure pure steam/WFI systems, modular process skids, bulk milk tanks and a rental program, Temp-Plate and Accu-Therm heat transfer products, and standardized components (tank heads/manways/fittings). 2025 results show strong momentum: $287.0M sales (+15.4%), 32.7% gross margin, $43.5M operating income (+20.2%), $34.7M net income (+16.9%), $37.53 EPS (+23.2%), and a record $243.6M backlog (+58.6%), setting up a capacity-driven growth phase.